Supplementary Figure S4 from scFv-Based “Grababody” as a General Strategy to Improve Recruitment of Immune Effector Cells to Antibody-Targeted Tumors
crossref（2023）
摘要
Supplementary Figure S4 PDF file 583K, In vivo activity of h4D5 in the T6-17 model
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要